CSPC Innovation Pharmaceutical Hits Day High with 9.06% Surge

CSPC Innovation Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 9.06% on June 29, 2026. The stock reached an intraday high of CNY 28.10, marking a notable performance against the backdrop of the China Shanghai Composite, which only rose by 1.16% on the same day. Over the past week, CSPC Innovation has shown a robust increase of 14.46%, contrasting sharply with the China Shanghai Composite's decline of 2.14%. However, the company's long-term performance remains a concern, with a year-to-date decline of 23.2% and a staggering 46.64% drop over the past year. Despite these challenges, CSPC Innovation has demonstrated resilience in the short term, with a remarkable 113.41% increase over the past three years. The company's market capitalization stands at CNY 33,148 million, categorizing it as a large-cap entity within the FMCG industry. Despite the recent uptick, CSPC Innovation's financial metrics indicate ongoing difficulties, including negative net profit and a low return on equity. Investors will be closely monitoring how these trends evolve in the coming periods.